Primary Site >> Liver Cancer
Gene >> CSF2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor. PMID: 2990610 |
Ref: [Recent trends in cancer treatment using cytokines]. PMID: 2471455 |
Ref: Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. PMID: 1701653 |
Ref: Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6. PMID: 1752786 |
Ref: Preoperative and postoperative cytokines in patients with cancer. PMID: 1320454 |
Ref: Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis. PMID: 7859412 |
Ref: Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. PMID: 8706021 |
Ref: Construction of a recombinant human GM-CSF/MCAF fusion protein and study on itsin vitro andin vivo antitumor effects. PMID: 18726295 |
Ref: Gene therapy with tumor vaccine increases the survival of hepatoma-bearing mice. PMID: 10533297 |
Ref: Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer. PMID: 11155819 |
Ref: Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma. PMID: 11295284 Ref: Effective treatment of small murine hepatocellular carcinoma by dendritic cells. PMID: 11679960 Ref: Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma. PMID: 11687898 |
Ref: Importance, mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors. PMID: 11880183 Ref: Locoregional immuno(bio)therapy for liver metastases. PMID: 11951214 Ref: Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes. PMID: 12067758 |
Ref: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. PMID: 12649744 Ref: Recombinant hepatitis B vaccination in renal failure patients. PMID: 12678888 Ref: Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model. PMID: 12680230 Ref: [The role of dendritic cell and macrophage in hepatoma antigen-presenting]. PMID: 12681057 Ref: Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors. PMID: 12731087 Ref: Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex. PMID: 12833133 Ref: Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. PMID: 14691921 |
Ref: Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: mechanisms for the superior antitumor activity of live tumor cell vaccines. PMID: 14966373 Ref: Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. PMID: 15044962 Ref: Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells. PMID: 15083197 Ref: [Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro]. PMID: 15196371 Ref: The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors. PMID: 15528337 Ref: A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture. PMID: 15534907 |
Ref: [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen]. PMID: 15918966 Ref: [Establishment of dendritomas by fusion of human dendritic cells with human hepatocellular carcinoma cell line HLE cells]. PMID: 16188141 Ref: Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses. PMID: 16237753 |
Ref: [A preliminary study on anti-liver cancer immunity of the virus-like particulate peptide-nucleic acid vaccine]. PMID: 16635296 Ref: [Cytotoxicity of cytotoxic T lymphocytes induced by the dendritic cells phagocytosing PLA-AFP218-226 micospheres Against hepatocellular carcinoma cell lines]. PMID: 16761412 Ref: Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma. PMID: 16795983 |
Ref: Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas. PMID: 17383529 |
Ref: [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma]. PMID: 18250039 Ref: [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine]. PMID: 18279611 Ref: Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. PMID: 18317360 Ref: Human CD4(+) T cells recognize an epitope within alpha-fetoprotein sequence and develop into TGF-beta-producing CD4(+) T cells. PMID: 18354237 Ref: Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. PMID: 18495536 Ref: [Dendritic cell vaccine modified by murine mAFP gene enhances immunoprotective effect on liver carcinogenesis and tumor development in mice]. PMID: 18788625 Ref: [Dendritic cells derived from hematopoietic stem cells pulsed with p53 induce a specific immune response against HMCC97 hepatocellular carcinoma cells]. PMID: 18931711 |
Ref: An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors. PMID: 18670453 Ref: [Combined effect of high mobile group box-1 protein and lipopolysaccharide on release of cytokines from human HepG2 cells]. PMID: 19751561 |
Ref: Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma. PMID: 20221274 Ref: [The killing effects of cytotoxic T lymphocytes stimulated by specific hAFP-derived peptides on hepatocellular cancer cells]. PMID: 20587317 Ref: Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model. PMID: 20679198 |
Ref: Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy. PMID: 21427706 |
Ref: Characterization of the cytokine expression profiles of the aorta and liver of young tumor necrosis factor alpha mutant mice. PMID: 22407569 Ref: Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor kappa B/Rel pathway. PMID: 22466945 Ref: The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC). PMID: 22640039 Ref: Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma. PMID: 23002366 |
Ref: Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer. PMID: 23305737 Ref: Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. PMID: 23396206 Ref: A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma. PMID: 23686226 Ref: Potential therapeutic value of dendritic cells loaded with NYESO1 protein for the immunotherapy of advanced hepatocellular carcinoma. PMID: 24085111 |
Ref: [Effect of PLGA nanoparticles conjugated with anti-OX40/anti-AFP mAbs on cytotoxicity of CTL cells against hepatocellular carcinoma]. PMID: 24721396 Ref: Summary of bi-shRNA/GM-CSF augmented autologous tumor cell immunotherapy (FANG) in advanced cancer of the liver. PMID: 24968881 Ref: Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage. PMID: 25401795 Ref: Immunotherapy of hepatocellular carcinoma. PMID: 30190978 |
Ref: Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. PMID: 25463538 Ref: The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594). PMID: 27512667 |
Ref: Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy. PMID: 27708236 Ref: Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma. PMID: 27853643 |
Ref: Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation. PMID: 28166197 Ref: [Experimental study on the immune response of fusion tumor vaccine of HepG2 and dendritic cells in vitro]. PMID: 28260295 Ref: Intrahepatic CD206(+) macrophages contribute to inflammation in advanced viral-related liver disease. PMID: 28483682 Ref: Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma. PMID: 28572167 Ref: Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats. PMID: 28830415 Ref: Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer. PMID: 28938619 Ref: Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator. PMID: 29238703 |
Ref: Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. PMID: 29408569 Ref: Effects of intratumoral injection of immunoactivator after microwave ablation on antitumor immunity in a mouse model of hepatocellular carcinoma. PMID: 29434784 Ref: Oncolytic activity of a novel influenza A virus carrying GM-CSF in hepatocellular carcinoma. PMID: 30205709 |